Study: Inhalable nasal spray slows cognitive decline in Alzheimer's patients

Share this article:
Insulin nasal spray could delay the decline of cognitive function in those with Alzheimer's and mild cognitive impairment, according to a new study.

Previous studies have indicated that insulin levels are lower in the central nervous systems of Alzheimer's patients, but this study shows that restoring insulin levels could have a protective effect.

Investigators from the University of Washington School of Medicine assigned 104 participants with certain types of mild cognitive impairment or Alzheimer's disease into three groups. Over a period of four months, one group received 20 international units of insulin nasal spray per day, one group received 40 IUs and the remaining third received a placebo.

The results of the pilot trail showed improved cognition and cerebral glucose metabolism in the insulin-receiving participants, the study authors wrote. “Taken together, these results provide an impetus for future clinical trials of intranasal insulin therapy and for further mechanistic studies of insulin's role in the pathogenesis of AD,” they said.

The results were published in the Archives of Neurology.
Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.